In the first cohort, using mass cytometry to study the peripheral blood mononuclear cells (PBMCs) of patients with mild cognitive impairment (MCI) or AD, the authors detected an increased population of CD3+CD8+CD27−CD45RA+ TEMRA cells. The gene discussed is CD8A; the disease is Alzheimer disease.